CoChat
Sign Up
Cited by 132Treatment of Major DepressionMental Health Treatment and AccessPsychotherapy Techniques and Applications

The DOI matches its Crossref record; 121 of the 124 references it cites were found in a registry or an index.

Evidence review: efficacy and effectiveness of antidepressant treatment in primary care

Simon, Gregory E·2002·General Hospital Psychiatry
DOI 10.1016/s0163-8343(02)00198-6
Open this paper in CoChat — free account

Abstract

This review considers evidence for the efficacy of pharmacotherapy among primary care patients with depressive disorders and reviews knowledge regarding the effectiveness of current practice. Strong evidence supports the efficacy of antidepressant pharmacotherapy for primary care patients with major depression and dysthymia with some evidence for pharmacotherapy of less severe depression. In general, available antidepressants appear equal in both efficacy and effectiveness. Treatment selection for any individual patient remains largely empirical, with few clinical characteristics predicting better or worse response to specific treatments. Strong evidence supports continuation treatment (i.e., at least six months of pharmacotherapy) for all patients and maintenance treatment (i.e., at least 24 months of pharmacotherapy) for those with chronic or recurrent depression. Unfortunately, few patients in primary care or specialty practice receive recommended levels of pharmacotherapy or recommended frequency of follow-up care. A number of recent studies have evaluated strategies to improve the quality of antidepressant treatment in primary care. Educational programs (including academic detailing and continuous quality improvement) have had little impact on patient outcomes. Key elements of effective care improvement programs include specific, evidence-based treatment protocols, organized patient education and active follow-up care.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0163-8343(02)00198-6

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 124 references

Research works printed but not linked: 9

  1. Tollefson, 1994, Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor, J Clin Psychiatry, 14, 385
  2. Linde, 2001, St John’s. Wort for depression (Cochrane Review)
  3. Katon, 1995, Collaborative management to achieve treatment guidelines, JAMA, 273, 1026, 10.1001/jama.273.13.1026 · DOI · Paper page
  4. Sclar, 1999, Ethnicity and the prescribing of antidepressant pharmacotherapy, Harv Rev Psychiatry, 7, 29
  5. Katzelnick, 1996, Prescribing patterns of antidepressant medications for depression in an HMO, Formulary, 31, 374
  6. Rost, 2001, Improving depression treatment in community primary care practice, Quality Enhancement by Strategic Teaming J Gen Intern Med, 16, 143
  7. Gerrity, 1999, Improving the recognition and management of depression, J Fam Pract, 48, 949
  8. Goldberg, 1998, A randomized controlled trial of CQI teams, and Academic Detailing, Jt Comm J Qual Impr, 24, 130
  9. Mundt, 2001, Effectiveness of antidepressant pharmacotherapy, Depress Anxiety, 13, 1, 10.1002/1520-6394(2001)13:1<1::AID-DA1>3.0.CO;2-S · DOI

Cited by

Sorted by citations

Items 101–132 of 132

Related

See all

Metadata

Authors
Simon, G. E.
Affiliations
Group Health Cooperative (US)
Corresponding author
Simon, Gregory E
ORCID
Simon, Gregory E
Venue
General Hospital Psychiatry
Publisher
Elsevier BV
Published
2002-07
Volume
24
Issue
4
Pages
213-224
ISSN
0163-8343 (ISSN-L)
DOI
10.1016/s0163-8343(02)00198-6
OpenAlex
W2056142446
Cited by
132
References
124
Citations by year
2025: 2 · 2024: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 6 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 11 · 2012: 7
FWCI
0.76
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • General Hospital Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (R01MH051338, MH51338)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
antidepressants, antidepressant treatment, major depressive disorder, dysthymia, primary care, treatment efficacy, treatment effectiveness, continuation treatment, maintenance therapy, follow-up care, educational programs, academic detailing, continuous quality improvement, treatment protocols, patient education
MeSH terms
Antidepressive Agents, Depressive Disorder, Humans, Mental Health Services, Primary Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review